SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-026869
Filing Date
2021-11-16
Accepted
2021-11-16 16:03:39
Documents
13
Period of Report
2021-11-16
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20211116_8k.htm   iXBRL 8-K 22597
  Complete submission text file 0001437749-21-026869.txt   169142

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20211116.xsd EX-101.SCH 4030
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20211116_def.xml EX-101.DEF 13402
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20211116_lab.xml EX-101.LAB 17563
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20211116_pre.xml EX-101.PRE 13373
6 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20211116_8k_htm.xml XML 4284
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 211416022
SIC: 2860 Industrial Organic Chemicals